Cargando…

Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF)

OBJECTIVES: Highly resistant microorganisms (HRMOs) are of high concern worldwide and are becoming increasingly less susceptible for antibiotics. To study the cost effectiveness of infection prevention measures in long-term care, it is essential to first fully understand the impact of HRMOs. The obj...

Descripción completa

Detalles Bibliográficos
Autores principales: van Rijt, Antonius M., Dik, Jan-Willem H., Lokate, Mariëtte, Postma, Maarten J., Friedrich, Alex W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258236/
https://www.ncbi.nlm.nih.gov/pubmed/30475904
http://dx.doi.org/10.1371/journal.pone.0208092
_version_ 1783374459777843200
author van Rijt, Antonius M.
Dik, Jan-Willem H.
Lokate, Mariëtte
Postma, Maarten J.
Friedrich, Alex W.
author_facet van Rijt, Antonius M.
Dik, Jan-Willem H.
Lokate, Mariëtte
Postma, Maarten J.
Friedrich, Alex W.
author_sort van Rijt, Antonius M.
collection PubMed
description OBJECTIVES: Highly resistant microorganisms (HRMOs) are of high concern worldwide and are becoming increasingly less susceptible for antibiotics. To study the cost effectiveness of infection prevention measures in long-term care, it is essential to first fully understand the impact of HRMOs. The objective of this study is to identify the costs associated with outbreaks caused by Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF). METHODS: After an outbreak of MRSA, Dutch LTCF can submit a reimbursement form to the Dutch Healthcare Authority (“Nederlandse Zorgautoriteit”; NZa) to get a part of the total costs reimbursed. In this study, we requested NZa forms for financial impact analysis. Details regarding the costs of the outbreak have been extracted from these forms and additionally specific LTCF have been visited in person to validate the data. RESULTS: 34 complete reimbursement forms from the period between 2011 and 2016 were received from the NZa and have been included. The median cost per patient per day was estimated at €83.80, varying between €16.89 and €1,820.09. We validated five reimbursement forms by visiting the facility and recalculating the costs. We found a non-significant positive difference of €26.07 compared with the original data (p = 0.068). CONCLUSIONS: This study is to our knowledge the first to give a national overview of total costs associated with an MRSA outbreak in LTCF in the Netherlands. Overall, costs per patient per day seem lower than in a hospital setting, although total costs are much higher due to the long term of care.
format Online
Article
Text
id pubmed-6258236
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62582362018-12-06 Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF) van Rijt, Antonius M. Dik, Jan-Willem H. Lokate, Mariëtte Postma, Maarten J. Friedrich, Alex W. PLoS One Research Article OBJECTIVES: Highly resistant microorganisms (HRMOs) are of high concern worldwide and are becoming increasingly less susceptible for antibiotics. To study the cost effectiveness of infection prevention measures in long-term care, it is essential to first fully understand the impact of HRMOs. The objective of this study is to identify the costs associated with outbreaks caused by Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF). METHODS: After an outbreak of MRSA, Dutch LTCF can submit a reimbursement form to the Dutch Healthcare Authority (“Nederlandse Zorgautoriteit”; NZa) to get a part of the total costs reimbursed. In this study, we requested NZa forms for financial impact analysis. Details regarding the costs of the outbreak have been extracted from these forms and additionally specific LTCF have been visited in person to validate the data. RESULTS: 34 complete reimbursement forms from the period between 2011 and 2016 were received from the NZa and have been included. The median cost per patient per day was estimated at €83.80, varying between €16.89 and €1,820.09. We validated five reimbursement forms by visiting the facility and recalculating the costs. We found a non-significant positive difference of €26.07 compared with the original data (p = 0.068). CONCLUSIONS: This study is to our knowledge the first to give a national overview of total costs associated with an MRSA outbreak in LTCF in the Netherlands. Overall, costs per patient per day seem lower than in a hospital setting, although total costs are much higher due to the long term of care. Public Library of Science 2018-11-26 /pmc/articles/PMC6258236/ /pubmed/30475904 http://dx.doi.org/10.1371/journal.pone.0208092 Text en © 2018 van Rijt et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
van Rijt, Antonius M.
Dik, Jan-Willem H.
Lokate, Mariëtte
Postma, Maarten J.
Friedrich, Alex W.
Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF)
title Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF)
title_full Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF)
title_fullStr Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF)
title_full_unstemmed Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF)
title_short Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF)
title_sort cost analysis of outbreaks with methicillin-resistant staphylococcus aureus (mrsa) in dutch long-term care facilities (ltcf)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258236/
https://www.ncbi.nlm.nih.gov/pubmed/30475904
http://dx.doi.org/10.1371/journal.pone.0208092
work_keys_str_mv AT vanrijtantoniusm costanalysisofoutbreakswithmethicillinresistantstaphylococcusaureusmrsaindutchlongtermcarefacilitiesltcf
AT dikjanwillemh costanalysisofoutbreakswithmethicillinresistantstaphylococcusaureusmrsaindutchlongtermcarefacilitiesltcf
AT lokatemariette costanalysisofoutbreakswithmethicillinresistantstaphylococcusaureusmrsaindutchlongtermcarefacilitiesltcf
AT postmamaartenj costanalysisofoutbreakswithmethicillinresistantstaphylococcusaureusmrsaindutchlongtermcarefacilitiesltcf
AT friedrichalexw costanalysisofoutbreakswithmethicillinresistantstaphylococcusaureusmrsaindutchlongtermcarefacilitiesltcf